Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Cancer Registry Software Market, by Type
6.1 Introduction
6.2 Integrated Software
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
6.3 Standalone Software
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 7. Global Cancer Registry Software Market, by Deployment Model
7.1 Introduction
7.2 Cloud-Based Models
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
7.3 On-Premise Models
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 8. Global Cancer Registry Software Market, by Database Type
8.1 Introduction
8.2 Commercial Databases
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
8.3 Public Databases
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 9. Global Cancer Registry Software Market, by Functionality
9.1 Introduction
9.2 Patient Care Management
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
9.3 Product Outcome Evaluation
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
9.4 Cancer Reporting to Meet State and Federal Regulations
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
9.5 Medical Research & Clinical Studies
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 10. Global Cancer Registry Software Market, by End User
10.1 Introduction
10.2 Hospitals & Medical Practices
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
10.3 Pharmaceutical, Biotechnology, and Medical Device Companies
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
10.4 Government Organizations & Research Centers
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
10.5 Others
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 11. Global Cancer Registry Software Market, by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.1.1 US
11.1.2 Canada
11.2.2 Latin America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 Italy
11.3.1.4 Spain
11.3.1.5 UK
11.3.1.6 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia-Pacific
11.5 Middle East & Africa
11.5.1 Middle East
11.5.2 Africa
Chapter 12. Company Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Key Development & Strategies
Chapter 13. Company Profiles
13.1 Onco, Inc.
13.1.1 Company Overview
13.1.2 Type Overview
13.1.3 Financials Overview
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.2 Rocky Mountain Cancer Data Systems
13.2.1 Company Overview
13.2.2 Type Overview
13.2.3 Financial Overview
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Elekta AB (PUB)
13.3.1 Company Overview
13.3.2 Type Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4 C/Net Solutions
13.4.1 Company Overview
13.4.2 Type Overview
13.4.3 Financial Overview
13.4.4 Key Development
13.4.5 SWOT Analysis
13.5 Electronic Registry Systems, Inc.
13.5.1 Company Overview
13.5.2 Type Overview
13.5.3 Financial overview
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.6 MCKESSON CORPORATION
13.6.1 Company Overview
13.6.2 Type Overview
13.6.3 Financial Overview
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.7 ORDINAL DATA, INC
13.7.1 Overview
13.7.2 Type Overview
13.7.3 Financial Overview
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.8 CONDUENT, INC
13.8.1 Overview
13.8.2 Type Overview
13.8.3 Financials
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.9 IBM
13.9.1 Overview
13.9.2 Type Overview
13.9.3 Financials
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.10 HIMAGINE SOLUTIONS INC
13.10.1 Overview
13.10.2 Type Overview
13.10.3 Financials
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.11 Others
Chapter 14 MRFR Conclusion
14.1 Key Findings
14.1.1 From CEO’s Viewpoint
14.1.2 Unmet Needs of the Market
14.2 Key Companies to Watch
14.3 Predictions for the Cancer Registry Software Industry
Chapter 15. Appendix
List of Tables
Table 1 Global Cancer Registry Software Market Synopsis, 2023–2032
Table 2 Global Cancer Registry Software Market Estimates and Forecast, 2023–2032 (USD Million)
Table 3 Global Cancer Registry Software Market, by Region, 2023–2032 (USD Million)
Table 4 Global Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 5 Global Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 6 Global Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 7 North America: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 8 North America: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 9 North America: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 10 US: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 11 US: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 12 US: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 13 Canada: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 14 Canada: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 15 Canada: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 16 South America: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 17 South America: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 18 South America: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 19 Europe: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 20 Europe: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 21 Europe: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 22 Western Europe: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 23 Western Europe: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 24 Western Europe: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 25 Eastern Europe: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 26 Eastern Europe: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 27 Eastern Europe: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 28 Asia-Pacific: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 29 Asia-Pacific: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 30 Asia-Pacific: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
Table 31 Middle East & Africa: Cancer Registry Software Market, by Type, 2023–2032 (USD Million)
Table 32 Middle East & Africa: Cancer Registry Software Market, by Deployment Model, 2023–2032 (USD Million)
Table 33 Middle East & Africa: Cancer Registry Software Market, by End User, 2023–2032 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure for Global Cancer Registry Software Market
Figure 3 Market Dynamics for Global Cancer Registry Software Market
Figure 4 Global Cancer Registry Software Market Share, by Type, 2023
Figure 5 Global Cancer Registry Software Market Share, by Deployment Model, 2023
Figure 6 Global Cancer Registry Software Market Share, by End User, 2023
Figure 7 Global Cancer Registry Software Market Share, by Region, 2023
Figure 8 North America: Cancer Registry Software Market Share, by Country, 2023
Figure 9 Europe: Cancer Registry Software Market Share, by Country, 2023
Figure 10 Asia-Pacific: Cancer Registry Software Market Share, by Country, 2023
Figure 11 Middle East & Africa: Cancer Registry Software Market Share, by Country, 2023
Figure 12 Global Cancer Registry Software Market: Company Share Analysis, 2023 (%)
Figure 13 Onco, Inc.: Key Financials
Figure 14 Onco, Inc.: Segmental Revenue
Figure 15 Onco, Inc.: Geographical Revenue
Figure 16 Rocky Mountain Cancer Data Systems: Key Financials
Figure 17 Rocky Mountain Cancer Data Systems: Segmental Revenue
Figure 18 Rocky Mountain Cancer Data Systems: Geographical Revenue
Figure 19 Elekta AB (PUB): Key Financials
Figure 20 Elekta AB (PUB): Segmental Revenue
Figure 21 Elekta AB (PUB): Geographical Revenue
Figure 22 Azbil Corporation: Key Financials
Figure 23 Azbil Corporation: Segmental Revenue
Figure 24 Azbil Corporation: Geographical Revenue
Figure 25 Electronic Registry Systems, Inc.: Key Financials
Figure 26 Electronic Registry Systems, Inc.: Segmental Revenue
Figure 27 Electronic Registry Systems, Inc.: Geographical Revenue
Figure 28 MCKESSON CORPORATION: Key Financials
Figure 29 MCKESSON CORPORATION: Segmental Revenue
Figure 30 MCKESSON CORPORATION: Geographical Revenue
Figure 31 ORDINAL DATA, INC: Key Financials
Figure 32 ORDINAL DATA, INC: Segmental Revenue
Figure 33 ORDINAL DATA, INC: Geographical Revenue
Figure 34 CONDUENT, INC: Key Financials
Figure 35 CONDUENT, INC: Segmental Revenue
Figure 36 CONDUENT, INC: Geographical Revenue
Figure 37 IBM: Key Financials
Figure 38 IBM: Segmental Revenue
Figure 39 IBM: Geographical Revenue
Figure 40 HIMAGINE SOLUTIONS INC: Key Financials
Figure 41 HIMAGINE SOLUTIONS INC: Segmental Revenue
Figure 42 HIMAGINE SOLUTIONS INC: Geographical Revenue
Figure 43 ZIRBUS technology GmbH: Key Financials
Figure 44 ZIRBUS technology GmbH: Segmental Revenue
Figure 45 ZIRBUS technology GmbH: Geographical Revenue
Figure 46 SP Scientific: Key Financials
Figure 47 SP Scientific: Segmental Revenue
Figure 48 SP Scientific: Geographical Revenue
Figure 49 LTE Scientific Ltd: Key Financials
Figure 50 LTE Scientific Ltd: Segmental Revenue
Figure 51 LTE Scientific Ltd: Geographical Revenue
Figure 52 Hitachi, Ltd: Key Financials
Figure 53 Hitachi, Ltd: Segmental Revenue
Figure 54 Hitachi, Ltd: Geographical Revenue
Figure 55 MechaTech Systems Ltd: Key Financials
Figure 56 MechaTech Systems Ltd: Segmental Revenue
Figure 57 MechaTech Systems Ltd: Geographical Revenue
